According to Santen Pharmaceutical
's latest financial reports the company has a price-to-book ratio of 1.64.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2022-12-31 | 1.36 | -22.54% |
2021-12-31 | 1.75 | -17.53% |
2020-12-31 | 2.13 | -22.41% |
2019-12-31 | 2.74 | 26.83% |
2018-12-31 | 2.16 | -15.39% |
2017-12-31 | 2.55 | 9.01% |
2016-12-31 | 2.34 | -26.98% |
2015-12-31 | 3.21 | 17.38% |
2014-12-31 | 2.73 | 20.47% |
2013-12-31 | 2.27 | 31.27% |
2012-12-31 | 1.73 | 2.43% |
2011-12-31 | 1.69 | 1.13% |
2010-12-31 | 1.67 | -9.5% |
2009-12-31 | 1.84 |